CB vs TXMD · P/E 14, rev $59.40B vs rev $1.8M
Chubb Ltd (CB) versus TherapeuticsMD Inc (TXMD) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
TherapeuticsMD Inc (TXMD) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported TXMD revenue for 2024-12-31 was $1.8M. Net income was -$2.2M. Revenue was up 35.3% from 2023-12-31 to 2024-12-31. TXMD currently screens at market cap $13.7M.
CB currently screens at market cap $114.26B and trailing P/E 13.7. TXMD currently screens at market cap $13.7M.
Not investment advice. Open the CB and TXMD stock pages for the full models.
Not investment advice.